Джозеф Меркола - Кето-навигатор

146. Willers SM, Devereux G, Craig LC, et al. Maternal food consumption during pregnancy and asthma, respiratory and atopic symptoms in 5-year-old children. Thorax . 2007 Sep; 62 (9): 773–779.

147. Janakiram NB, Mohammed A, Rao CV. Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer. Cancer Metastasis Rev . 2011 Dec; 30 (3–4): 507–523.

148. Gonzalez MJ, Schemmel RA, Gray JI, et al. Effect of dietary fat on growth of MCF-7 and MDA-MB231 human breast carcinomas in athymic nude mice: relationship between carcinoma growth and lipid peroxidation product levels. Carcinogenesis . 1991 Jul; 12 (7): 1231–1235.

149. Gonzalez MJ, Schemmel RA, Dugan L, Jr., et al. Dietary fish oil inhibits human breast carcinoma growth: a function of increased lipid peroxidation. Lipids. 1993 Sep; 28 (9): 827–832.

150. Hudson EA, Beck SA, Tisdale MJ. Kinetics of the inhibition of tumour growth in mice by eicosapentaenoic acid-reversal by linoleic acid. Biochem Pharmacol . 1993 Jun 9; 45 (11): 2189–2194.

151. Conklin KA. Dietary polyunsaturated fatty acids: impact on cancer chemotherapy and radiation. Altern Med Rev . 2002 Feb; 7 (1): 4–21.

152. Там же.

153. Там же.

154. Там же.

1. Ogden CL, Carroll MD, Kit BK, et al. Prevalence of obesity in the United States, 2009–2010. NCHS data brief . 2012 Jan: (82) 1–8.

2. Yki-Jarvinen H. Fat in the liver and insulin resistance. Ann Med . 2005; 37 (5): 347–356.

3. Jung SH, Ha KH, Kim DJ. Visceral Fat Mass Has Stronger Associations with Diabetes and Prediabetes than Other Anthropometric Obesity Indicators among Korean Adults. Yonsei Med J . 2016 May 1; 57 (3): 674–680.

4. Sheth SG, Chopra Sanjive. Epidemiology, clinical features, and diagnosis of nonalcoholic fatty liver disease in adults [Интернет]. UpToDate . 2018. Доступно по адресу http://www.uptodate.com/contents/epidemiology-clinical-features-anddiagnosis-of-nonalcoholic-fatty-liver-disease-in-adults.

5. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther . 2011 Aug; 34 (3): 274–285.

6. Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology . 2011 Jan; 140 (1): 124–131.

7. Menke A, Casagrande S, Geiss L, et al. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA . 2015 Sep 8; 314 (1): 1021–1029.

8. Lopategi A, Lopez-Vicario C, Alcaraz-Quiles J, et al. Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction. Mol Cell Endocrinol . 2016 Jan 5; 419: 44–59.

9. Там же.

10. Claria J, Nguyen BT, Madenci AL, et al. Diversity of lipid mediators in human adipose tissue depots. Am J Physiol Cell Physiol . 2013 Jun 15; 304 (12): C1141–1149.

11. Claria J, Dalli J, Yacoubian S, et al. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. J Immunol . 2012 Sep 1; 189 (5): 2597–2605.

12. Lopategi A, Lopez-Vicario C, Alcaraz-Quiles J, et al. Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction. Mol Cell Endocrinol . 2016 Jan 5; 419: 44–59.

13. White PJ, Arita M, Taguchi R, et al. Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice. Diabetes . 2010 Dec; 59 (12): 3066–30673.

14. Neuhofer A, Zeyda M, Mascher D, et al. Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation. Diabetes . 2013 Jun; 62 (6): 1945–1956.

15. Hellmann J, Tang Y, Kosuri M, et al. Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. FASEB J . 2011 Jul; 25 (7): 2399–2407.

16. Lopategi A, Lopez-Vicario C, Alcaraz-Quiles J, et al. Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction. Mol Cell Endocrinol . 2016 Jan 5; 419: 44–59.

17. Там же.

18. Guyenet SJ, Carlson SE. Increase in adipose tissue linoleic acid of US adults in the last half century. Advances in Nutrition . 2015 Nov 1; 6 (6): 660–664.

19. Surette ME, Koumenis IL, Edens MB, et al. Inhibition of leukotriene synthesis, pharmacokinetics, and tolerability of a novel dietary fatty acid formulation in healthy adult subjects. Clin Ther . 2003 Mar; 25 (3): 948–971.

20. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr . 2000 Jan; 71 (1 Suppl): 343s–8s.

21. Manole, Bogdan A. “Effect of Alpha-Linolenic Acid on Global Fatty Oxidation in Adipocytes and Skeletal Muscle Cells” [honors thesis project]. University of Tennessee; 2011.

22. Ikemoto S, Takahashi M, Tsunoda N, et al. High-fat diet-induced hyperglycemia and obesity in mice: differential effects of dietary oils. Metabolism . 1996 Dec; 45 (12): 1539–1546.

23. Hill JO, Peters JC, Lin D, et al. Lipid accumulation and body fat distribution is influenced by type of dietary fat fed to rats. Int J Obes Relat Metab Disord . 1993 Apr; 17 (4): 223–236.

24. Flachs P, Rossmeisl M, Kuda O, et al. Stimulation of mitochondrial oxidative capacity in white fat independent of UCP1: a key to lean phenotype. Biochim Biophys Acta . 2013 May; 1831 (5): 986–1003.

25. Flachs P, Horakova O, Brauner P, et al. Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat. Diabetologia . 2005 Nov; 48 (11): 2365–2375.

26. Hensler M, Bardova K, Jilkova ZM, et al. The inhibition of fat cell proliferation by n-3 fatty acids in dietary obese mice. Lipids Health Dis . 2011 Aug 2; 10: 128.

27. Ruzickova J, Rossmeisl M, Prazak T, et al. Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue. Lipids. 2004 Dec; 39 (12): 1177–1785.

28. Spalding KL, Arner E, Westermark PO, et al. Dynamics of fat cell turnover in humans. Nature . 2008 Jun 5; 453 (7196): 783–787.

29. Azain MJ. Role of fatty acids in adipocyte growth and development. J Anim Sci . 2004 Mar; 82 (3): 916–924.

30. Hutley LJ, Newell FM, Joyner JM, et al. Effects of rosiglitazone and linoleic acid on human preadipocyte differentiation. Eur J Clin Invest . 2003 Jul; 33 (7): 574–581.

31. Alvheim AR, Malde MK, Osei-Hyiaman D, et al. Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity. Obesity (Silver Spring) . 2012 Oct; 20 (1): 1984–1994.

32. Massiera F, Saint-Marc P, Seydoux J, et al. Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern? J Lipid Res . 2003 Feb; 44 (2): 271–279.

33. Moon RJ, Harvey NC, Robinson SM, et al. Maternal plasma polyunsaturated fatty acid status in late pregnancy is associated with offspring body composition in childhood. J Clin Endocrinol Metab . 2013 Jan; 98 (1): 299–307.

34. Donahue SM, Rifas-Shiman SL, Gold DR, et al. Prenatal fatty acid status and child adiposity at age 3 y: results from a US pregnancy cohort. Am J Clin Nutr . 2011 Apr; 93 (4): 780–788.

35. Hill JO, Peters JC, Lin D, et al. Lipid accumulation and body fat distribution is influenced by type of dietary fat fed to rats. Int J Obes Relat Metab Disord . 1993 Apr; 17 (4): 223–236.

36. Su W, Jones PJ. Dietary fatty acid composition influences energy accretion in rats. J Nutr . 1993 Dec; 123 (12): 2109–2114.

37. Baillie RA, Takada R, Nakamura M, et al. Coordinate induction of peroxisomal acyl-CoA oxidase and UCP-3 by dietary fish oil: a mechanism for decreased body fat deposition. Prostaglandins Leukot Essent Fatty Acids .1999 MayJun; 60 (5–6): 351–356.

38. Belzung F, Raclot T, Groscolas R. Fish oil n-3 fatty acids selectively limit the hypertrophy of abdominal fat depots in growing rats fed high-fat diets. Am J Physiol . 1993 Jun; 264 (6 Pt 2): R1111–1118.

39. Kunesova M, Braunerova R, Hlavaty P, et al. The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. Physiol Res . 2006; 55 (1): 63–72.

40. Там же.

41. Thorsdottir I, Tomasson H, Gunnarsdottir I, et al. Randomized trial of weightloss-diets for young adults varying in fish and fish oil content. Int J Obes (Lond) . 2007 Oct; 31 (1): 1560–1566.

42. Mater MK, Thelen AP, Pan DA, et al. Sterol response element-binding protein 1c (SREBP1c) is involved in the polyunsaturated fatty acid suppression of hepatic S14 gene transcription. J Biol Chem . 1999 Nov; 274 (46): 32725–32732.

43. Hulbert AJ, Else PL. Membranes as possible pacemakers of metabolism. J Theor Biol . 1999 Aug 7; 199 (3): 257–274.

44. Allport S. The queen of fats: why omega-3s were removed from the western diet and what we can do to replace them . Oakland (CA): University of California Press; 2006. 232 p.

45. Hulbert AJ, Else PL. Membranes as possible pacemakers of metabolism. J Theor Biol .1999 Aug 7; 199 (3): 257–274.

46. Там же.

47. Smith GI, Atherton P, Reeds DN, et al. Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial. Am J Clin Nutr . 2011 Feb; 93 (2): 402–412.

48. Smith GI, Julliand S, Reeds DN, et al. Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults. Am J Clin Nutr . 2015 Jul; 102 (1): 115–122.

49. Gingras AA, White PJ, Chouinard PY, et al. Long-chain omega-3 fatty acids regulate bovine whole-body protein metabolism by promoting muscle insulin signalling to the Akt-mTOR-S6K1 pathway and insulin sensitivity. J Physiol . 2007 Feb 15; 579 (Pt 1): 269–284.

50. Alexander JW, Saito H, Trocki O, et al. The importance of lipid type in the diet after burn injury. Ann Surg .1986 Jul; 204 (1): 1–8.

51. Berbert AA, Kondo CR, Almendra CL, et al. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis. Nutrition . 2005 Feb; 21 (2): 131–136.

52. Murphy RA, Mourtzakis M, Chu QS, et al. Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy. Cancer . 2011 Apr 15; 117 (8): 1775–1782.

53. Rodacki CL, Rodacki AL, Pereira G, et al. Fish-oil supplementation enhances the effects of strength training in elderly women. Am J Clin Nutr . 2012 Feb; 95 (2): 428–436.

54. Ryan AM, Reynolds JV, Healy L, et al. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg . 2009 Mar; 249 (3): 355–363.